Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib

IsraelRecruitingPHASE2

Conditions

Non-squamous NSCLC

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sheba Medical Center, Ramat Gan, Israel, Israel
Sheba · Jair.Bar@sheba.health.gov.il · 972546288901
Sheba Medical Center, Jusidman Cancer Center, Ramat Gan, Israel, Israel
Contact: Study coordinator (Jair Bar, Prof.) · jair.bar@sheba.gov.il
Contact: Study coordinator (Abigal Ryklin) · abigal.ryklin@sheba.health.gov.il
Contact: Study coordinator (Jair Bar, Prof.)

View source on ClinicalTrials.gov Contact study team (email)